Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer

Prostate

Volumn 76, Issue 4, 2016, Pages 339-348

  Nordström, Tobias ^a,b,c   Van Blarigan, Erin L ^a,b   Ngo, Vy ^a   Roy, Ritu ^a   Weinberg, Vivian ^a   Song, Xiaoling ^d   Simko, Jeffry ^a,b   Carroll, Peter R ^a   Chan, June M ^a,b   Paris, Pamela L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

carotenes; genetic polymorphisms; genomic instability; lycopene; prostate cancer

Indexed keywords

ALPHA CAROTENE; BETA CAROTENE; CAROTENOID; COPPER ZINC SUPEROXIDE DISMUTASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; LYCOPENE; MANGANESE SUPEROXIDE DISMUTASE; XRCC1 PROTEIN; ALPHA-CAROTENE; ANTIOXIDANT; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CANCER GRADING; COPY NUMBER VARIATION; CROSS-SECTIONAL STUDY; GENOMIC INSTABILITY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BLOOD; DNA REPAIR; GENETICS; GENOTYPE; MIDDLE AGED; ODDS RATIO; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RISK FACTOR;

AGED; ANTIOXIDANTS; BETA CAROTENE; CAROTENOIDS; CROSS-SECTIONAL STUDIES; DNA REPAIR; GENOMIC INSTABILITY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 84955720349     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.23125     Document Type: Article

References (39)

1. Siegel RL, Miller KD, Jemal A,. Cancer statistics. CA Cancer J Clin 2015; 65: 5-29.
2. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC,. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995; 87: 1767-1776.
3. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC,. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 2002; 94: 391-398.
4. Etminan M, Takkouche B, Caamaño-Isorna F,. The role of tomato products and lycopene in the prevention of prostate cancer: A meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 2004; 13: 340-345.
5. Bosetti C, Talamini R, Montella M, Negri E, Conti E, Franceschi S, La Vecchia C,. Retinol, carotenoids and the risk of prostate cancer: A case-control study from Italy. Int J Cancer 2004; 112: 689-692.
6. Jian L, Du C-J, Lee AH, Binns CW,. Do dietary lycopene and other carotenoids protect against prostate cancer ? Int J Cancer 2005; 113: 1010-1014.
7. Jian L, Lee AH, Binns CW,. Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr 2007; 16 (Suppl 1): 453-457.
8. Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ, Giovannucci E,. Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen era. JNCI J Natl Cancer Institute 2014; 106: djt43-djt40.
9. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, Haapakoski J, Malila N, Rautalahti M, Ripatti S, Mäenpää H, Teerenhovi L, Koss L, Virolainen M, Edwards BK,. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Iincidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90: 440-446.
10. Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, Dixon LB, Urban DA, Crawford ED, Hayes RB,. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 92-98.
11. Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, Thompson IM, Diet,. Supplement use, and prostate cancer risk: Results from the prostate cancer prevention trial. Am J Epidemiol 2010; 172: 566-577.
12. Beilby J, Ambrosini GL, Rossi E, de Klerk NH, Musk AW,. Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk. Eur J Clin Nutr 2010; 64: 1235-1238.
13. Virtamo J, Taylor PR, Kontto J, Männistö S, Utriainen M, Weinstein SJ, Huttunen J, Albanes D,. Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Int J Cancer 2014; 135: 178-185.
14. Huang H-Y, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ,. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 2003; 157: 335-344.
15. Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB,. Serum lycopene, other carotenoids, and prostate cancer risk: A nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2007; 16: 962-968.
16. Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, Egevad L, Tjønneland A, Johnsen NF, Overvad K, Linseisen J, Rohrmann S, Boeing H, Pischon T, Psaltopoulou T, Trichopoulou A, Trichopoulos D, Palli D, Vineis P, Tumino R, Berrino F, Kiemeney L, Bueno-de-Mesquita HB, Quirõs JR, González CA, Martinez C, Larrañaga N, Chirlaque MD, Ardanaz E, Stattin P, Hallmans G, Khaw K-T, Bingham S, Slimani N, Ferrari P, Rinaldi S, Riboli E,. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr 2007; 86: 672-681.
17. Gill JK, Franke AA, Steven Morris J, Cooney RV, Wilkens LR, Le Marchand L, Goodman MT, Henderson BE, Kolonel LN,. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: The multiethnic cohort. Cancer Causes Control 2009; 20: 1161-1171.
18. Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB, Thompson IM,. Serum lycopene concentration and prostate cancer risk: Results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2011; 20: 638-646.
19. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ,. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cancer Res 1999; 59: 1225-1230.
20. Wu K, Erdman JW, Schwartz SJ, Platz EA, Leitzmann M, Clinton SK, DeGroff V, Willett WC, Giovannucci E,. Plasma and dietary carotenoids, and the risk of prostate cancer: A nested case-control study. Cancer Epidemiol Biomarkers Prev 2004; 13: 260-269.
21. Giovannucci E,. Commentary: Serum lycopene and prostate cancer progression: A re-consideration of findings from the prostate cancer prevention trial. Cancer Causes Control 2011; 22: 1055-1059.
22. Abe M, Xie W, Regan MM, King IB, Stampfer MJ, Kantoff PW, Oh WK, Chan JM,. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU Int 2011; 107: 126-134.
23. Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, Stampfer MJ, Ma J,. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005; 65: 2498-2504.
24. Richman EL, Carroll PR, Chan JM,. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer 2012; 131: 201-210.
25. Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson J, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll PR, Rubin MA, Collins C, van Dekken H,. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 2004; 13: 1303-1313.
26. Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll PR, Chan JM,. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate 2013; 73: 1786-1795.
27. Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW,. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer. J Clin Oncol 2009; 27: 3577-3583.
28. Paris PL, Weinberg V, Albo G, Roy R, Burke C, Simko J, Carroll P, Collins C,. A group of genome-based biomarkers that add to a Kattan Nomogram for predicting progression in men with high-risk prostate cancer. Clin Cancer Res 2010; 16: 195-202.
29. Venkatraman ES, Olshen AB,. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007; 23: 657-663.
30. Willett W,. Nutritional epidemiology, 3rd ed. Oxford: Oxford University Press; 2012.
31. Visakorpi T, Kallioniemi AH, Syvänen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP,. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995; 55: 342-347.
32. Kavanaugh CJ, Trumbo PR, Ellwood KC,. The U. S. Food and Drug Administration's evidence-based review for qualified health claims: Tomatoes, lycopene, and cancer. J Natl Cancer Inst 2007; 99: 1074-1085.
33. World Cancer Research Fund/American Institute for Cancer Research., Food, Nutrition, and Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC 2007.
34. Wei B, Zhou Y, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, Hu Q, Wang Q, Wang Z, Yan Z,. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: A meta-analysis. Prostate Cancer Prostatic Dis 2011; 14: 225-231.
35. Karyadi DM, Zhao S, He Q, McIntosh L, Wright JL, Ostrander EA, Feng Z, Stanford JL,. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families. Int J Cancer 2015; 136: 2166-2171.
36. Zhang J, Dhakal IB, Greene G, Lang NP, Kadlubar FF,. Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: Effects modified by plasma antioxidants. Urology 2010; 75: 779-785.
37. Kim J, Mizokami A, Shin M, Izumi K, Konaka H, Kadono Y, Kitagawa Y, Keller ET, Zhang J, Namiki M,. SOD3 acts as a tumor suppressor in PC-3 prostate cancer cells via hydrogen peroxide accumulation. Anticancer Res 2014; 34: 2821-2831.
38. Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll PR, Chan JM,. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate 2015; 75: 60-69.
39. Al-Delaimy WK, Natarajan L, Sun X, Rock CL, Pierce JP, Pierce JJ,. Women's Healthy Eating and Living (WHEL) Study Group. Reliability of plasma carotenoid biomarkers and its relation to study power. Epidemiology 2008; 19: 338-344.